NCT01854736View on ClinicalTrials.gov

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Allergic Rhinitis Due to Grass Pollens

Interventions

DRUG

Grazax

GRAZAX

OTHER

Placebo

Trial Locations (2)

28006

Hospital Universitario de La Princesa, Madrid

28040

Hospital Clínico Universitario San Carlos, Madrid

All Listed Sponsors

lead

ALK-Abelló A/S

INDUSTRY

NCT01854736 - Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate | Biotech Hunter | Biotech Hunter